Glomerulosclerosis, Focal Segmental

5 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Glomerulosclerosis, Focal Segmental
Treatment and conditionWhere it standsTrials
Apecotrep for glomerulosclerosis, focal segmentalPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Brivekimig for glomerulosclerosis, focal segmentalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Frexalimab for glomerulosclerosis, focal segmentalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo for glomerulosclerosis, focal segmentalPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Rilzabrutinib for glomerulosclerosis, focal segmentalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1